Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Phase 3 Coronary Artery Disease Trials

6 Phase 3 trials for Coronary Artery Disease. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.

What is a Phase 3 trial?

Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
RECRUITINGPhase 3NCT07297589

Epicardial Cardiac Fat-CT (EPIC-CT)

Both globally and nationally, heart disease remains the leading cause of death overall and across genders, with ischemic heart disease being the primary cause. It is now...

Sponsor: Instituto Mexicano del Seguro SocialEnrolling: 1361 location
RECRUITINGPhase 3NCT04020263

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined...

Cardiogenic shock (CS) mortality remains high (40%). Despite their frequent use, few clinical outcome data are available to guide the initial selection of vasoactive drug...

Sponsor: Pr Bruno LEVYEnrolling: 61020 locations
RECRUITINGPhase 3NCT05918861

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

This is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic...

Sponsor: DalCor PharmaceuticalsEnrolling: 200020 locations
RECRUITINGPhase 3NCT07439133

Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography...

The primary objective of this study is to evaluate the effectiveness of visual reading in XTR004 PET myocardial perfusion imaging (MPI) for detecting restrictive stenosis, using...

Sponsor: Sinotau Pharmaceutical GroupEnrolling: 3955 locations
RECRUITINGPhase 3NCT05764057

DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

Recent clinical trials have proven the cardiovascular benefits of new medications for patients with heart failure with reduced ejection fraction (HFrEF), especially sodium-glucose...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 4501 location
RECRUITINGPhase 3NCT06399692

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 60018 locations